• 'A case of autoimmune hepatitis associated with the PCSK9 inhibitor alirocumab'
• A Case of Autoimmune Hepatitis Initially Manifesting as Hepatic Encephalopathy
• A case of visceral leishmaniasis masquerading as autoimmune hepatitis
• A novel case report of benign recurrent intrahepatic cholestasis-associated USP53 genetic mutation in a Pakistani girl
• A Rare Case of Bullous Morphea Associated with Autoimmune Hepatitis
• Acute liver failure
• Acute onset autoimmune hepatitis has become the most frequent clinical phenotype in the Bologna cohort
• Acute presentation of autoimmune hepatitis -from acute hepatitis to ALF and ACLF
• Advanced MR imaging for detection of liver fibrosis and inflammation in autoimmune hepatitis: a state-of-the-art review
• An Aggressive Case of Cryoglobulinemia and Membranoproliferative Glomerulonephritis: A Case Report
• Annular elastolytic giant cell granuloma associated with autoimmune hepatitis: Response to ciclosporin
• Argonaute-2 autoantibodies: a promising biomarker for predicting mortality in HBV-related acute-on-chronic liver failure patients with cirrhosis
• Aspergillus flavus/oryzae Arthritis of the Knee Joint: First Case in Türkiye
• Associations between modifiable risk factors and hepatocellular carcinoma: a trans-ancestry Mendelian randomization study
• Autoimmune hepatitis developed after COVID-19 vaccination and ameliorated temporarily but relapsed or stopped improving, and finally resolved by steroid therapy:a report of three cases
• Autoimmune hepatitis presenting as severe anemia
• Autoimmune Hepatitis with Metabolic Dysfunction-associated Fatty Liver Disease
• B and T cells: (Still) the dominant orchestrators in autoimmune hepatitis
• B cell depletion for autoimmune liver diseases: A retrospective review of indications and outcomes
• Case report: liver failure as a debut of autoimmune hepatitis triggered by dengue virus in a pregnant woman
• CDK4/6 inhibitor-induced liver injury: Clinical phenotypes and role of corticosteroid treatment
• Characteristics of liver volume and pathological changes with different stages of liver fibrosis in chronic liver disease
• Classical autoimmune hepatitis and the IgG4-associated autoimmune hepatitis in paediatric patients
• Co-occurrence of anti-phospholipid syndrome and posterior reversible encephalopathy syndrome in a patient with Autoimmune hepatitis: A case report
• Comparison of the recommendation of international autoimmune hepatitis pathology group 2022 and the simplified criteria for autoimmune hepatitis 2008: A preliminary study
• Concanavalin-A-Induced Acute Liver Injury in Mice
• Detection of polyreactive immunoglobulin G facilitates diagnosis in children with autoimmune hepatitis
• Diagnosis and presenting features of autoimmune hepatitis at a central referral hospital in South Africa
• Diagnostic accuracy of an uncorrected native T1 mapping sequence for liver fibrosis and inflammation in autoimmune hepatitis: a prospective study using histopathology as reference standard
• Diagnostic Accuracy of Transient Elastography for Staging Liver Fibrosis in Autoimmune Liver Diseases: A Systematic Review and Meta-Analysis
• Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy
• Diagnostic features of autoimmune hepatitis in SARS-CoV-2-vaccinated vs. unvaccinated individuals
• Dual roles of myeloid-derived suppressor cells in various diseases: a review
• Dynamics of liver stiffness measurement and clinical course of primary biliary cholangitis
• Early and late complications of hematopoietic stem cell transplantation
• Early Graft Loss With Suspected Seventh-Day Syndrome Following Pediatric Liver Transplantation
• Etiology-Specific Effects of Impaired Functional Status on Liver Transplant Outcomes
• Evaluation of autoimmune liver disease antibodies in hepatitis patients
• Evaluation of four chatbots in autoimmune liver disease: A comparative analysis
• Exploring the Pathogenesis of Autoimmune Liver Diseases from the Heterogeneity of Target Cells
• FGF4 ameliorates the liver inflammation by reducing M1 macrophage polarization in experimental autoimmune hepatitis
• Fibrillary Glomerulonephritis Leading to End-Stage Renal Disease in the Absence of Active or Chronic Hepatitis C Infection: Current Insights
• FKBP38 deletion exacerbates ConA-induced hepatitis by promoting the immune response through the MCP-1/p38 pathway
• Genetic Mutations Associated With TNFAIP3 (A20) Haploinsufficiency and Their Impact on Inflammatory Diseases
• Giant cell hepatitis associated with autoimmune hemolytic anemia: more evidence for B-cell depletion therapy for a rare immune mediated disease of infancy
• Glucocorticoid efficacy and treatment strategies for drug-induced liver injury: a literature review
• Glycyrrhizic acid alleviates concanavalin A-induced acute liver injury by regulating monocyte-derived macrophages
• Good long-term outcomes of primary sclerosing cholangitis in childhood
• Growth differentiation factor 15: Emerging role in liver diseases
• Hepatitis B reactivation in PsA patients: an SLR and meta-analysis for IL-17, IL-23 and JAK inhibitors
• Hepatitis C Virus and Molecular Mimicry
• Hepatitis-related adverse events associated with immune checkpoint inhibitors in cancer patients: an observational, retrospective, pharmacovigilance study using the FAERS database
• Hepatopulmonary Syndrome in a Patient With Autoimmune Hepatitis Without Liver Cirrhosis: A Case Report
• Hypoglycemia and Multivitamins
• Ibuprofen-Induced Pancytopenia and Erythema Multiforme in an Elderly Female Patient
• Identification of a mimotope of a complex gp41 Human Immunodeficiency VIrus epitope related to a non-structural protein of <em>Hepacivirus</em> previously implicated in Kawasaki disease
• IFNgamma initiates TLR9-dependent autoimmune hepatitis in DNase II deficient mice
• Immune-Related Adverse Events Associated with Atezolizumab: Insights from Real-World Pharmacovigilance Data
• Immunogenicity of Covishield vaccine in patients with autoimmune rheumatic diseases
• Immunological crossroads: The intriguing dance between hepatitis C and autoimmune hepatitis
• Inborn Errors of Immunity in Adults with Autoimmune Liver Diseases
• Influenza vaccination-associated cryoglobulinemic vasculitis
• Investigation of the relationship of tissue-resident gammadelta T cells and IL-17 gene expression with the pathogenesis of autoimmune hepatitis
• Knockout of C6orf120 in Rats Alleviates Concanavalin A-induced Autoimmune Hepatitis by Regulating Macrophage Polarization
• Label-free detection of ConA-induced T-lymphocyte activation at single-cell level by microfluidics
• Literature review and case study of recurrent EPGA with elevated IgG4 and positive HBsAg successfully treated with rituximab
• Liver enzyme profiles after initiating biological treatment in children with inflammatory bowel diseases
• Liver Transplantation Profile Among Teenagers in the United States
• Macrophage Activation Syndrome in Viral Sepsis
• Membranous nephropathy: pathogenesis and treatments
• Obtaining first-line induction in autoimmune hepatitis: aren't we underestimating prednisolone?
• Optimizing thiopurine therapy in autoimmune hepatitis: A multi-center study on monitoring metabolite profiles and co-therapy with allopurinol
• PLCG2 Mutation in a Patient Presenting with Type 2 Autoimmune Hepatitis
• PNPLA3 I148 M genetic variant in autoimmune hepatitis characterises advanced disease at diagnosis and reduced survival free of cirrhotic events and liver-related mortality
• Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitors
• Prevalence and significance of autoantibodies in children with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis
• Prophylactic IL-23 blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
• Quantitative Liver Imaging in Children
• Reactivation of hepatitis B virus infection - an important aspect of multifaceted problem
• Remodeling of T-cell mitochondrial metabolism to treat autoimmune diseases
• Risk factors for Non-Hodgkin's lymphoma in autoimmune disease: a large database analysis
• Risks and benefits of anti-TNF therapy for ulcerative colitis in a patient with autoimmune hepatitis-related cirrhosis: Case report
• Rituximab-Associated Liver Toxicity Without Known Viral Reactivation
• Role of Sirolimus and Rituximab in the Treatment of Autoimmune Hepatitis
• Rosacea and autoimmune liver diseases: a two-sample Mendelian randomization study
• Selective Immunoglobulin M Deficiency in Patients with Autoimmune Liver Diseases
• Simultaneous Occurrence of Wilson's Disease, Autoimmune Hepatitis, and Hereditary Hemochromatosis: A Diagnostic Challenge
• Simultaneous portal vein thrombosis and splenic vein thrombosis in a COVID-19 patient: A case report and review of literature
• Successful A2 to O Simultaneous Liver and Kidney Transplantation in the Setting of Pre-operative Positive HLA Crossmatch: A Case Report
• The 507th case: hemolytic anemia, parvovirus B19, and multiple organ dysfunction
• The Autoimmune Gender Gap: A Rare Case of a Male Patient With Overlapping Autoimmune Hepatitis and Primary Biliary Cholangitis
• The Effectiveness of Measuring Thiopurine Metabolites in the Treatment of Autoimmune Hepatitis Patients
• The evolving landscape of autoimmune hepatitis: an ambispective cohort study
• The phenotypic landscape of primary biliary cholangitis and autoimmune hepatitis variants
• The role of T regulatory cells in the immunopathogenesis of HIV: Clinical implications
• Trends of autoimmune liver disease inpatient hospitalization and mortality from 2011 to 2017: A United States nationwide analysis
• Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis - an ELTR study
• Unmet needs in autoimmune hepatitis: Results of the prospective multicentre European Reference Network Registry (R-LIVER)
• Updates on the Diagnosis and Management of Fibrillary Glomerulonephritis
• Worse fibro-inflammatory activity on diagnostic liver biopsy adversely impacts biochemical remission in autoimmune hepatitis